Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-
A4452 Mitomycin C8 CitationSummary: Inhibits DNA synthesis,antibiotic and antitumor agent -
A4448 Actinomycin D55 CitationSummary: RNA polymerase inhibitor -
A1902 Z-VAD-FMK216 CitationTarget: CaspasesSummary: pan-caspase inhibitor -
A1901 Q-VD-OPh88 CitationTarget: CaspasesSummary: pan-caspase inhibitor -
N1663 Madecassoside1 CitationTarget: AntioxidantsSummary: Major triterpenoid Centella asiatica component -
A3007 ABT-263 (Navitoclax)58 CitationTarget: Bcl-2|Bcl-wSummary: Bcl-2 family inhibitor -
B5965 Tamoxifen18 CitationTarget: PKCSummary: estrogen receptor modulator -
A3847 SU54169 CitationTarget: VEGFRSummary: VEGFR2 inhibitor -
B8314 Chlorin e61 Citation -
BA3005 MirodenafilSummary: Mirodenafil (SK3530) is an orally effective, reversible, selective inhibitor of phosphodiesterase 5.


